Top in ID: COVID-19 in the White House, timing of flu vaccination
During a press conference held by the Infectious Diseases Society of America, experts said it will be important to monitor White House staffers and administration for COVID-19. It was the top story in infectious disease last week.
Another top story was about concerns among experts that people may be opting out of influenza vaccination, increasing the risk for a “twindemic.”
Read these and more top stories in infectious disease below:
Close monitoring ‘critical’ for Trump, White House staff
Rajesh T. Gandhi, MD, FIDSA, said it will be important to closely monitor President Donald J. Trump and other White House staffers and administration officials who recently tested positive for COVID-19. Read more.
Q&A: Timing of flu vaccination in patients with COVID-19
Healio spoke with Infectious Disease News Editorial Board Member Raghavendra Tirupathi, MD, FACP, about the clinical considerations in vaccinating patients with COVID-19 for influenza. Read more.
‘New standard of care’ for MERS reduces mortality in hospitalized patients
A combination of interferon beta-1b and lopinavir-ritonavir reduced mortality in hospitalized patients with Middle East respiratory syndrome, according to results from a randomized clinical trial in The New England Journal of Medicine. Read more.
Time to include children in COVID-19 vaccine trials, experts say
Currently, none of the COVID-19 vaccines in clinical development are being tested among people aged younger than 18 years, but this could change soon, said Paul A. Offit, MD. Read more.
COVID-19 cases among young adults spike 55% in 1 month
COVID-19 cases among adults aged 18 to 22 years increased 55% in the United States between August and September, according to findings published in MMWR. Read more.